6 products were found matching "Cay10010309-%25"!
No results were found for the filter!
Protectin D1
Item number: Cay10010390-25
Protectin D1 is a specialized pro-resolving mediator (SPM) synthesized from docosahexaenoic acid (DHA, Cay-90310). DHA is oxidized to 16S,17S-epoxy-protectin, which is converted to protectin D1 enzymatically. Protectin D1 increases phagocytosis of apoptotic polymorphonuclear leukocytes (PMNs) by macrophages in a...
| Keywords: | Neuroprotectin D1, Neuroprotectin D1/Protectin D1, NPD1, PD1, 10R,17S-dihydroxy-4Z,7Z,11E,13E,15Z,19Z-docosahexaenoic acid |
| Application: | Specialized pro-resolving mediator (SPM) |
| CAS | 660430-03-5 |
| MW: | 360.5 D |
From 163.00€
*
CAY10554
Item number: Cay10010301-25
Cyclin-dependent kinases (CDKs) are key regulators of cell cycle progression and are therefore promising therapeutic targets for cancer and neurodegenerative diseases. Cyclin-dependent kinases (CDKs) are key regulators of cell cycle progression and are therefore promising therapeutic targets for cancer and...
| Keywords: | BML-259, N-[5-(1-methylethyl)2-thiazolyl]-benzeneacetamide |
| Application: | CDK5 inhibitor, CDK2 inhibitor |
| CAS | 267654-00-2 |
| MW: | 260.4 D |
From 86.00€
*
AG-18
Item number: Cay10010300-25
Protein tyrosine kinase (PTK) inhibitors are potential antiproliferative agents for diseases caused by the hyperactivity of PTKs. Tyrphostins are a class of antiproliferative compounds which act as protein tryrosine kinase blockers. PTK inhibitors which preferentially inhibit the epidermal growth factor (EGF)...
| Keywords: | RG-50810, RG-50858, TX 825, Tyrphostin 23, Tyrphostin AG-18, 2-[(3,4-dihydroxyphenyl)methylene]-propanedinitrile |
| Application: | EGF receptor kinase inhibitor |
| CAS | 118409-57-7 |
| MW: | 186.1 D |
From 46.00€
*
SB 202190
Item number: Cay10010399-25
SB 202190 is a selective, potent, cell-permeable inhibitor of p38 MAP kinases, inhibiting p38alpha (SAPK2A, MAPK14) and p38beta (SAPK2B, MAPK11) with IC50 values of 50 and 100 nM, respectively. When tested at 10 µM, SB 202190 has negligible effects on a range of other kinases, including other MAP kinases (ERKs,...
| Keywords: | 4-[4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazol-2-yl]-phenol |
| Application: | MAP kinases Inhibitor |
| CAS | 152121-30-7 |
| MW: | 331.3 D |
From 39.00€
*
Lovastatin Hydroxy Acid (sodium salt)
Item number: Cay10010339-25
Lovastatin hydroxy acid is a potent and competitive inhibitor of HMG-CoA reductase (Ki = 0.6 nM). It is the more potent, open ring, hydroxy acid form of its prodrug, lovastatin (Cay-10010338).Formal Name:...
| Keywords: | 2-methyl-1S,2,3R,7S,8S,8aR-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthal... |
| Application: | NF-kappaB activation inhibitor |
| CAS | 75225-50-2 |
| MW: | 444.5 D |
From 50.00€
*
1-Oleoyl-2-hydroxy-sn-glycero-3-PA
Item number: Cay10010093-25
1-Oleoyl-2-hydroxy-sn-glycero-3-PA (1-Oleoyl LPA) is a species of lysophosphatidic acid (LPA) containing oleic acid at the sn-1 position. Phosphatidic acid is produced either directly through the action of phospholipase D (PLD) or through a two step process involving liberation of diacylglycerol (DAG) by...
| Keywords: | 1-Oleoyl LPA, Oleoyl-sn-3-Glycerophosphate, 1-O-9Z-octadecenoyl-sn-glyceryl-3-phosphoric acid |
| Application: | Bioactive lipid assays |
| CAS | 65528-98-5 |
| MW: | 436.5 D |
From 35.00€
*